Literature DB >> 3345345

The inactive beta globin gene on a gamma delta beta thalassemia chromosome has a normal structure and functions normally in vitro.

P T Curtin1, Y W Kan.   

Abstract

We have previously described an English family with gamma delta beta-thalassemia in which a large deletion stops 25 kilobases (kb) upstream from the beta-globin gene locus, and yet the beta-globin gene is inactive in vivo. Affected family members had a beta-thalassemia minor phenotype with a normal hemoglobin A2 level. Gene mapping showed that these subjects were heterozygous for a chromosome bearing a large deletion that began in the G gamma-globin gene, extended through the epsilon-globin gene, and continued upstream for at least 75 kb. The A gamma-, delta-, and beta-globin gene loci on this chromosome were intact. To examine the possibility that an additional defect was present in the beta-globin gene, we cloned, sequenced, and examined the expression of the beta-globin gene from the affected chromosome. No mutation was found in the beta-globin gene sequence from 990 base-pairs 5' to the cap site to 350 basepairs 3' to the polyadenylation signal. The gene was subcloned into an expression vector and introduced into HeLa cells. Analysis of RNA derived from these cells, using a ribonuclease protection assay, revealed qualitatively and quantitatively normal transcription. Thus a structurally and functionally normal beta-globin gene is inactive in the presence of a large deletion more than 25 kb upstream. The loss of beta-globin gene function may be due to disturbance of chromatin conformation caused by the deletion or may be the result of loss of upstream sequences that are necessary for beta-globin gene expression in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345345

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Beta-thalassaemia: molecular pathogenesis and clinical variability.

Authors:  A E Kulozik
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.

Authors:  Gabriela G Loots; Michaela Kneissel; Hansjoerg Keller; Myma Baptist; Jessie Chang; Nicole M Collette; Dmitriy Ovcharenko; Ingrid Plajzer-Frick; Edward M Rubin
Journal:  Genome Res       Date:  2005-06-17       Impact factor: 9.043

3.  Mechanism of DNase I hypersensitive site formation within the human globin locus control region.

Authors:  C H Lowrey; D M Bodine; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

4.  Differential expression of alpha- and beta-globin genes in erythroleukemic cell lines.

Authors:  N Beru; P B Maples; O Hermine; E Goldwasser
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

5.  Human beta-globin gene expression in transgenic mice is enhanced by a distant DNase I hypersensitive site.

Authors:  P T Curtin; D P Liu; W Liu; J C Chang; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like globin" genes.

Authors:  D Y Tuan; W B Solomon; I M London; D P Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 7.  Erythrocyte disorders in the perinatal period.

Authors:  Laurie A Steiner; Patrick G Gallagher
Journal:  Semin Perinatol       Date:  2007-08       Impact factor: 3.300

8.  The mouse beta-globin locus control region: hypersensitive sites 3 and 4.

Authors:  G Jiménez; K B Gale; T Enver
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

9.  The effect of Nigella sativa supplementation on cardiovascular risk factors in obese and overweight women: a crossover, double-blind, placebo-controlled randomized clinical trial.

Authors:  Elham Razmpoosh; Sara Safi; Azadeh Nadjarzadeh; Hossien Fallahzadeh; Nooshin Abdollahi; Mahta Mazaheri; Majid Nazari; Amin Salehi-Abargouei
Journal:  Eur J Nutr       Date:  2020-09-02       Impact factor: 5.614

10.  Activation of the beta-globin locus control region precedes commitment to the erythroid lineage.

Authors:  G Jiménez; S D Griffiths; A M Ford; M F Greaves; T Enver
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.